
James Clifford
Articles
-
Jan 8, 2025 |
financemagnates.com | James Clifford
Surpassing the eight million registered voters mark and recording significant growth in several areas, SoSoValue announced that it has raised $15 million in a Series A. This exciting news comes off the back of a $4.15 million seed round in July 2024, bringing the total investment to nearly $20 million. This recent Series A funding was co-led by HSG and SmallSpark, HSG being an existing shareholder who also led the previous seed round.
-
Dec 9, 2024 |
financemagnates.com | James Clifford
Whether you're new to the game or a seasoned pro, navigating the risky and complex world of forex trading can be overwhelming, especially when investors and traders are bombarded with unreliable information and deceitful platforms. This confusion increases risks, misinformed decisions, and potential financial losses. If only a single trusted source could evaluate, validate, and guide you to safer and more transparent decisions.
-
Dec 2, 2024 |
financemagnates.com | Louis Parks |James Clifford |Damian Chmiel |IFX Expo Dubai
What are you looking for? What are you looking for?
-
Dec 2, 2024 |
financemagnates.com | James Clifford
Memecoins may be fun, but Solana needs substance. While the blockchain’s speed, low fees, and scalability have fueled an explosion of memecoins, capturing retail traders and driving community engagement, the long-term health of the ecosystem depends on more than fleeting hype. Real-World Assets (RWA) present a transformative alternative and offer sustainable growth and real-world value. In early 2024, RWA emerged as the , delivering an impressive 285.6% return.
-
Nov 11, 2024 |
financemagnates.com | James Clifford
XVC Tech, one of the leading venture capital (VC) firms committed to exploring potential investment opportunities in technology solutions, is entering the budding healthcare tech sector. Through a strategic investment into Shealth.AI—an Artificial Intelligence (AI) start-up dedicated to improving the healthcare sector—this is the VC firm’s first foray into the billion-dollar AI-based healthcare market.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →